Leonard S. Schleifer

2016

In 2016, Leonard S. Schleifer earned a total compensation of $28.3M as President and Chief Executive Officer at Regeneron Pharmaceuticals, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$2,235,600
Option Awards$24,631,012
Salary$1,242,000
Other$228,908
Total$28,337,520

Schleifer received $24.6M in option awards, accounting for 86.92% of the total pay in 2016.

Schleifer also received $2.2M in non-equity incentive plan, $1.2M in salary and $228.9K in other compensation.

Rankings

In 2016, Leonard S. Schleifer's compensation ranked 50th out of 14,063 executives tracked by ExecPay. In other words, Schleifer earned more than 99.6% of executives.

ClassificationRankingPercentile
All
50
out of 14,063
100th
Division
Manufacturing
11
out of 5,498
100th
Major group
Chemicals And Allied Products
5
out of 1,871
100th
Industry group
Drugs
4
out of 1,505
100th
Industry
Pharmaceutical Preparations
4
out of 1,147
100th
Source: SEC filing on April 26, 2019.

Schleifer's colleagues

We found two more compensation records of executives who worked with Leonard S. Schleifer at Regeneron Pharmaceuticals in 2016.

2016

George Yancopoulos

Regeneron Pharmaceuticals

Chief Scientific Officer

2016

Robert Landry

Regeneron Pharmaceuticals

Chief Financial Officer

News

In-depth

You may also like